HIT Consultant November 10, 2023
Fred Pennic

What You Should Know:

RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma.

– The need for the RapidAI solution is urgent, with SDH cases in US patients expected to increase by nearly 80% before 2040.

AI Module for Detection of Hemispheric Subdural Hematomas

Rapid SDH leverages AI to help neurocritical care teams identify suspected hemispheric subdural hemorrhage faster and with a higher degree of accuracy than traditional methods.

Key features of Rapid SDH include:

– The only hemorrhagic and trauma package to feature hemispheric SDH, ICH and Hyperdensity for faster...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Provider, Technology
Google promises new AI models for drug discovery
Alphabet CEO on AI as a Workplace Collaborator
Tencent profit surges 90% as it touts AI revenue boost and ramps up spending
How are AI and ML transforming healthcare software development?
GPUs go biological: BBB unveils Bionode, lab-grown, living neuron compute for AI applications

Share This Article